3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
NETWORK
2
OTHER
1
NIH
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Colorectal Neoplasms
240
Rectal Neoplasms
93
Colonic Neoplasms
91
Pancreatic Neoplasms
87
Stomach Neoplasms
68
Neoplasm Metastasis
47
Esophageal Neoplasms
41
Neoplasms
36
Small Cell Lung Carcinoma
29
Lung Neoplasms
29
Neuroblastoma
28
Glioblastoma
28
Glioma
27
Brain Neoplasms
26
Carcinoma, Non-Small-Cell Lung
22
Adenocarcinoma Of Esophagus
20
Gliosarcoma
19
Breast Neoplasms
18
Astrocytoma
18
Esophageal Squamous Cell Carcinoma
17
Central Nervous System Neoplasms
17
Unspecified Adult Solid Tumor, Protocol Specific
16
Oligodendroglioma
13
Adenocarcinoma
13
Rhabdomyosarcoma
10
Gastrointestinal Neoplasms
10
Biliary Tract Neoplasms
10
Sarcoma
9
Gallbladder Neoplasms
9
Cholangiocarcinoma
9
Interventions
Filgrastim
10
Cyclophosphamide
8
Granulocyte Colony-Stimulating Factor
6
Melphalan
5
Busulfan
5
Vincristine
4
Topotecan
4
Temozolomide
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Ifosfamide
4
Etoposide
4
Thiotepa
3
Radiotherapy
3
Mesna
3
Itraconazole
3
Doxorubicin
3
Cisplatin
3
Carboplatin
3
sargramostim
2
fludarabine
2
Therapeutics
2
Sirolimus
2
Radiotherapy, Intensity-Modulated
2
Nivolumab
2
Drug Therapy
2
Bone Marrow Transplantation
2
Blood Specimen Collection
2
Amplified Fragment Length Polymorphism Analysis
2
trioctyl phosphine oxide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Wilms Tumor
×
Irinotecan
×
Clear all
NCT05384821
2026-03-18
MetroWilms
Centre Oscar Lambret
Phase 1/2
Recruiting
28 enrolled